Literature DB >> 33534027

Peripheral Administration of Nitroglycerin in Pulseless Ventricular Tachycardia due to Cocaine-Induced Coronary Vasospasm.

Savalan Babapoor-Farrokhran1, Aditi Kalla2, Deanna Gill3, Asma Gulab4, Sahil Banka2, Sanjog Kalra2.   

Abstract

Cocaine use accounts for 40% of the annual drug use related emergency department visits in the United States. Cocaine use is hence recognized as a major health problem. Cocaine blocks the presynaptic reuptake of norepinephrine and dopamine. The resulting increased adrenergic activity leads to vasoconstriction. Additionally, via various mechanisms, cocaine leads to a prothrombotic state and increases myocardial demand. Cocaine can cause coronary vasospasm and is therefore, associated with acute myocardial injury even in the absence of pre-existing atherosclerotic coronary artery disease. Nitroglycerin has a class 1C indication by the ACCF/AHA guidelines for patients with ST-segment elevation or depression that accompanies ischemic chest discomfort in the setting of cocaine use. It has been shown to reverse cocaine-induced coronary vasospasm and chest pain. In this case report, for the first time, we discuss how intravenous administration of high dose nitroglycerin to a patient in pulseless ventricular tachycardia with angiographically confirmed vasospasm induced by cocaine resulted in return of spontaneous circulation.

Entities:  

Keywords:  Cocaine-induced coronary vasospasm; Coronary vasospasm; Nitroglycerin; ST elevation myocardial infarction

Mesh:

Substances:

Year:  2021        PMID: 33534027     DOI: 10.1007/s12012-021-09635-4

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  6 in total

1.  Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.

Authors:  Edward J Cone; Angela H Sampson-Cone; William D Darwin; Marilyn A Huestis; Jonathan M Oyler
Journal:  J Anal Toxicol       Date:  2003-10       Impact factor: 3.367

2.  Protracted elimination of cocaine metabolites in long-term high-dose cocaine abusers.

Authors:  R D Weiss; F H Gawin
Journal:  Am J Med       Date:  1988-12       Impact factor: 4.965

3.  Triggering of myocardial infarction by cocaine.

Authors:  M A Mittleman; D Mintzer; M Maclure; G H Tofler; J B Sherwood; J E Muller
Journal:  Circulation       Date:  1999-06-01       Impact factor: 29.690

4.  Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine.

Authors:  Michael L Smith; Eric Shimomura; Buddha D Paul; Edward J Cone; W David Darwin; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2010-03       Impact factor: 3.367

5.  Recurrent coronary vasoconstriction caused by intranasal cocaine: possible role for metabolites.

Authors:  W C Brogan; R A Lange; D B Glamann; L D Hillis
Journal:  Ann Intern Med       Date:  1992-04-01       Impact factor: 25.391

6.  Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin.

Authors:  W C Brogan; R A Lange; A S Kim; D J Moliterno; L D Hillis
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

  6 in total
  1 in total

Review 1.  Oxidative Stress and Cocaine Intoxication as Start Points in the Pathology of Cocaine-Induced Cardiotoxicity.

Authors:  Ekaterina Georgieva; Yanka Karamalakova; Radostina Miteva; Hristo Abrashev; Galina Nikolova
Journal:  Toxics       Date:  2021-11-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.